That's exactly what they'll be studying to see if it's statistically relevant. They're being super cautious. Some would say over cautious but I think it's fine since J&J is currently only 5-10% of the vaccine supply going out. Which means a slight slow down in vaccine supply but not as big a deal as AZ in Europe since that is their main supply.